Rachel D. Crouch

Also affiliated with Vanderbilt University, Center for Discovery

Pharmacology, Toxicology and PharmaceuticsComputer ScienceBiochemistry, Genetics and Molecular BiologyMedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Cytochromes P450 2C8 and 3A Catalyze the Metabolic Activation of the Tyrosine Kinase Inhibitor Masitinib”.

Cytochromes P450 2C8 and 3A Catalyze the Metabolic Activation of the Tyrosine Kinase Inhibitor Masitinib

Chemical Research in Toxicology(2022)10.1021/acs.chemrestox.2c00057

N/A

0.576DataRank · unranked

14 citations

D. Spencer Oskin, Rachel D. Crouch, Matthew J. Vergne, Klarissa D. Jackson, Bethany D. Latham

Discovery of VU0467319: an M1 Positive Allosteric Modulator Candidate That Advanced into Clinical Trials

ACS Chemical Neuroscience(2024)10.1021/acschemneuro.4c00769

N/A

0.457DataRank · unranked

11 citations

Michael R. Wood, Changho Han, Shaun R. Stauffer, Joseph D. Panarese, Bruce J. Melancon +21 more

Bioactivation and reactivity research advances – 2021 year in review

Drug Metabolism Reviews(2022)10.1080/03602532.2022.2097254

N/A

0DataRank · unranked

3 citations

Upendra A. Argikar, Sungjoon Cho, Rachel D. Crouch, James P. Driscoll, Carley J. S. Heck +9 more